Recently, GLP-1 agonists have been proven to display anti-inflammatory and immune-modulatory properties, thus justifying their pleiotropic effects resulting in protection from the chronic complications of diabetes mellitus [21]. This evidence concerns the gene GCG and diabetes mellitus.